Investing in global measles and rubella elimination is needed to avert deaths and advance health equity
- PMID: 36113510
- PMCID: PMC9904879
- DOI: 10.1016/S2214-109X(22)00388-6
Investing in global measles and rubella elimination is needed to avert deaths and advance health equity
Conflict of interest statement
The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention. We declare no competing interests.
Comment on
-
Feasibility of measles and rubella vaccination programmes for disease elimination: a modelling study.Lancet Glob Health. 2022 Oct;10(10):e1412-e1422. doi: 10.1016/S2214-109X(22)00335-7. Lancet Glob Health. 2022. PMID: 36113527 Free PMC article.
References
-
- Moss WJ, Shendale S, Lindstrand A, et al. Feasibility assessment of measles and rubella eradication. Vaccine 2021; 39: 3544–59. - PubMed
-
- Fine PEM, Mulholland KM, Scott JA, Edmonds WJ. Community protection. In: Plotkin SA, Orenstein WA, Offit PA, Edwards KM, eds. Plotkin’s vaccines, 7th edn. Amsterdam: Elsevier, 2018: 1512–31.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
